XPOVIO® is the first and only approved XPO1 inhibitor in Malaysia. XPOVIO® has been approved for multiple indications in eight markets across the APAC region. Antengene has submitted new drug applications (NDAs) for XPOVIO® in other ASEAN markets including Thailand and Indonesia with…
Month: August 2024
Indicio Academy offers training and certification in all aspects of the business and technology of decentralized identity. The partnership signals growing interest in verifiable identity and data solutions in Japan. TOKYO, Aug. 5, 2024 /PRNewswire/ — Indicio, the global market leader in…
Indicio Academy offers training and certification in all aspects of the business and technology of decentralized identity. The partnership signals growing interest in verifiable identity and data solutions in Japan. TOKYO, Aug. 5, 2024 /PRNewswire/ — Indicio, the global market leader in…
VANCOUVER, BC, Aug. 5, 2024 /PRNewswire/ – August 6, 2024 – Sydney, Australia HIGHLIGHTS Significant Exploration Target outlines the potential for additional tonnage at the Shaakichiuwaanaan Property (formerly known as Corvette). Approximately 146 to 231 Mt at 1.0 to 1.5% Li2O. The…
LOS ANGELES, Aug. 5, 2024 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against STMicroelectronics N.V. (“ST” or “the Company”) (NYSE: STM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by…
LOS ANGELES, Aug. 5, 2024 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Five Below, Inc. (“Five Below” or “the Company”) (NASDAQ: FIVE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder…
LOS ANGELES, Aug. 5, 2024 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against Helios Technologies, Inc. (“Helios” or “the Company”) (NYSE: HLIO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated…